Dr. Jeffrey Tan


Jeffrey S. Tan, Ph.D.
Senior Research Scientist, Small Molecule Design and Development
Eli Lilly and Company

Dr. Jeffrey S. Tan obtained his Ph.D. at Purdue University in the Department of Industrial and Physical Pharmacy under the supervision of Professor Kenneth R. Morris. His research focused on developing novel algorithms for quantum mechanically derived partial atomic charges with a level of accuracy suitable for use in solid-state calculations.

Dr. Tan joined Eli Lilly and Company in 2007 in the pre-formulation group as the pharmaceutical development scientist in the discovery-development interface. He is currently a member of the Small Molecule Design and Development Modeling and Simulations group where he is actively developing and applying in silico and in silicoin vitro hybrid tools to study mechanisms affecting drug product performance such as drug absorption, in vivo dissolution and precipitation, solubility, and stability in an effort to better design and optimize pre-clinical and early phase clinical trial formulations.